The narrative for cannabis in 2026 is defined by a massive shift in federal policy.

: Large brokers like Charles Schwab and Fidelity allow you to buy both major-exchange stocks and OTC stocks, which include most U.S. Multi-State Operators (MSOs).

: The investing app Public offers curated "Cannabis" themes for easier navigation. The Story: A Federal Pivot (2026)

To buy marijuana stocks, you need a brokerage account with a firm that supports trading on major exchanges (NYSE/NASDAQ) or the over-the-counter (OTC) markets, where many U.S. operators are listed.

: Following a December 2025 executive order, the U.S. DOJ and DEA moved medical marijuana to Schedule III in April 2026. This reclassification acknowledges medical value and is expected to remove the "280E" tax burden, allowing companies to finally deduct standard business expenses.

: While recreational use remains federally illegal, the move to Schedule III has sparked administrative hearings (starting June 29, 2026) to explore broader federal acceptance, banking access, and potential listing on major U.S. exchanges. Top Picks for 2026

: Most retail platforms (e.g., Robinhood ) support Canadian companies and ETFs on major exchanges but often block OTC-listed U.S. cannabis companies.